TVARDI THERAPEUTICS, INC. Operating Lease, Weighted Average Discount Rate, Percent
TVARDI THERAPEUTICS, INC. (TVRD) had Operating Lease, Weighted Average Discount Rate, Percent of 9.50% as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent · last filed 2026-08-14
- 2026-06-30: Operating Lease, Weighted Average Discount Rate, Percent 9.50%.
- 2026-03-31: Operating Lease, Weighted Average Discount Rate, Percent 9.50%.
- 2025-12-31: Operating Lease, Weighted Average Discount Rate, Percent 9.50%.
- 2025-09-30: Operating Lease, Weighted Average Discount Rate, Percent 9.50%.
| Period end | Operating Lease, Weighted Average Discount Rate, Percent | Operating Lease, Weighted Average Discount Rate, Percent as first filed |
|---|---|---|
| 2026-06-30 | 9.50% 10-Q · filed 2026-08-14 | |
| 2026-03-31 | 9.50% 10-Q · filed 2026-05-08 | |
| 2025-12-31 | 9.50% 10-K · filed 2026-03-31 | |
| 2025-09-30 | 9.50% 10-Q · filed 2025-11-13 | |
| 2025-06-30 | 9.50% 10-Q · filed 2026-08-14 | |
| 2025-03-31 | 9.50% 10-Q · filed 2026-05-08 | |
| 2024-12-31 | 9.50% 10-K · filed 2026-03-31 | |
| 2024-09-30 | 9.50% 10-Q · filed 2025-11-13 | |
| 2024-06-30 | 9.50% 10-Q · filed 2025-08-14 | 12.80% 10-Q · filed 2024-08-14 |
| 2024-03-31 | 12.80% 10-Q · filed 2025-05-13 | |
| 2023-12-31 | 12.80% 10-K · filed 2025-03-11 | |
| 2023-09-30 | 12.40% 10-Q · filed 2024-11-14 | |
| 2023-06-30 | 7.00% 10-Q · filed 2024-08-14 | |
| 2023-03-31 | 7.00% 10-Q · filed 2024-05-13 | |
| 2022-12-31 | 7.00% 10-K · filed 2024-03-06 | |
| 2022-09-30 | 7.00% 10-Q · filed 2023-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |